{"id":882,"date":"2026-04-24T00:03:37","date_gmt":"2026-04-24T00:03:37","guid":{"rendered":"https:\/\/decodepeptides.com\/?product=recovery-stack-bundle"},"modified":"2026-04-25T00:29:10","modified_gmt":"2026-04-25T00:29:10","slug":"recovery-stack-bundle","status":"publish","type":"product","link":"https:\/\/decodepeptides.com\/de\/product\/recovery-stack-bundle\/","title":{"rendered":"Recovery Stack \u2014 BPC-157 + TB500 & GHK-Cu"},"content":{"rendered":"
\n

Recovery Stack \u2014 BPC-157 + TB500 & GHK-Cu: The Most Comprehensive Tissue Repair Research Bundle Available<\/h2>\n

The Wiederherstellungsstapel<\/strong> combines three of the most extensively studied regenerative peptides in preclinical research: BPC-157<\/strong> (Body Protective Compound-157), TB500<\/strong> (Thymosin Beta-4 synthetic analogue), and GHK-Cu<\/strong> (Copper Tripeptide-1). Each peptide targets a distinct but complementary biological pathway \u2014 tendon and gut healing, systemic angiogenesis and cell migration, and extracellular matrix remodelling \u2014 making this the most complete tissue repair research protocol available.<\/p>\n\n

BPC-157: The FAK-Paxillin Healing Peptide<\/h2>\n

Was ist BPC-157?<\/h3>\n

BPC-157 is a synthetic pentadecapeptide (15 amino acids: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) derived from a protective protein found in human gastric juice. First isolated by Professor Sikiric at the University of Zagreb, Croatia, it has since become one of the most cited peptides in preclinical injury-healing research, with over 200 peer-reviewed publications spanning tendon, muscle, bone, gut, and neural repair models.<\/p>\n

Mechanism of Action<\/h3>\n

BPC-157 exerts its regenerative effects primarily through activation of the FAK-paxillin pathway<\/strong> (Focal Adhesion Kinase \/ paxillin signalling), central to cell migration, proliferation, and adhesion during tissue repair. It also upregulates VEGF<\/strong> (Vascular Endothelial Growth Factor) expression, stimulating angiogenesis to supply nutrients to injured tissue.<\/p>\n

    \n
  • Modulation of the NO-system<\/strong> (nitric oxide synthase), maintaining vascular tone and reducing ischemic injury<\/li>\n
  • Upregulation of EGR-1<\/strong> (Early Growth Response protein 1) \u2014 a transcription factor driving collagen gene expression in fibroblasts<\/li>\n
  • Cytoprotection of the gastrointestinal epithelium via prostaglandin and somatostatin modulation<\/li>\n
  • Anti-inflammatory effects through inhibition of NF-κB signalling<\/li>\n<\/ul>\n

    Key Preclinical Findings<\/h3>\n
      \n
    • Tendon healing:<\/strong> In rat transection models, BPC-157 significantly accelerated Achilles tendon healing vs. saline controls, with histological evidence of improved collagen fibre organisation (Pevec et al., 2010 \u2014 J Physiol Pharmacol<\/em>)<\/li>\n
    • Muscle repair:<\/strong> Quadriceps and gastrocnemius crush-injury models showed faster functional recovery and reduced fibrosis (Sikiric et al., 2011 \u2014 J Physiol Pharmacol<\/em>)<\/li>\n
    • Gut healing:<\/strong> Healed anastomotic dehiscence, ulcers and colitis lesions in rodent models across 30+ published studies (Sikiric et al., 2018 \u2014 Curr Pharm Des<\/em>)<\/li>\n
    • Bone repair:<\/strong> Accelerated bone defect healing via upregulation of BMP-2 and OPG (Sikiric et al., 2013 \u2014 J Physiol Pharmacol<\/em>)<\/li>\n
    • CNS neuroprotection:<\/strong> Reduced dopaminergic and serotonergic disruption in brain injury models; peripheral nerve healing acceleration documented in multiple studies (Sikiric et al., 2016 \u2014 Brain Behav Immun<\/em>)<\/li>\n<\/ul>\n

      BPC-157 Research References<\/h3>\n
        \n
      1. Sikiric P et al. \u201eStabiles gastrales Pentadecapeptid BPC 157.\u201c Aktuelles pharmazeutisches Design<\/em>, 2018;24(18):1906\u20131922.<\/li>\n
      2. Pevec D et al. “Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application.” Medical Science Monitor<\/em>, 2010;16(3):BR81\u201388.<\/li>\n
      3. Chang CH et al. “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” J Appl Physiol<\/em>, 2011;110(3):774\u2013780.<\/li>\n
      4. Tkalcevic VI et al. “Enhancement by PL 14736 of granulation and collagen organization in healing wounds.” Eur J Pharmacol<\/em>, 2007;570(1-3):212\u2013221.<\/li>\n<\/ol>\n\n

        TB500 (Thymosin Beta-4): Angiogenesis and Cell Migration Activator<\/h2>\n

        What Is TB500?<\/h3>\n

        TB500 is a synthetic analogue of the naturally occurring peptide Thymosin Beta-4 (Tβ4)<\/strong>, a 43-amino-acid protein found in virtually all human and animal cells. It plays a fundamental role in actin dynamics \u2014 the molecular machinery behind cell movement and structural integrity. TB500 specifically refers to the active fragment of Tβ4: the sequence Ac-LKKTETQ<\/strong> (amino acids 17\u201323), which retains the key biological activities of the full molecule at significantly reduced molecular weight.<\/p>\n

        Mechanism of Action<\/h3>\n
          \n
        • G-actin sequestration:<\/strong> Binds and sequesters monomeric G-actin, maintaining a pool available for rapid mobilisation during tissue repair \u2014 driving lamellipodia formation in fibroblasts, endothelial cells, and keratinocytes<\/li>\n
        • Angiogenesis:<\/strong> Promotes endothelial cell differentiation and tube formation; upregulates MMP-2 for basement membrane remodelling and new vessel ingrowth<\/li>\n
        • Anti-inflammatory:<\/strong> Downregulates TNF-α and IL-6 via NF-κB pathway inhibition; reduces neutrophil recruitment to injury sites<\/li>\n
        • Cardiomyocyte survival:<\/strong> Activates ILK (Integrin-Linked Kinase) \/ Akt pro-survival signalling in cardiac cells under ischemic stress<\/li>\n<\/ul>\n

          Key Preclinical and Clinical Findings<\/h3>\n
            \n
          • Wound healing:<\/strong> Tβ4 administered systemically accelerated full-thickness dermal wound closure in db\/db diabetic mice by 42% vs. controls (Malinda KM et al., 1999 \u2014 FASEB J<\/em>)<\/li>\n
          • Cardiac repair:<\/strong> Post-MI administration in mice activated epicardial progenitor cells (EPDCs), reduced infarct size by 30%, and improved ejection fraction (Smart N et al., 2007 \u2014 Natur<\/em>)<\/li>\n
          • Corneal healing:<\/strong> Phase II clinical trial data showed Tβ4 eye drops accelerated corneal epithelial healing in dry eye and neurotrophic keratopathy (Sosne G et al., 2010 \u2014 Cornea<\/em>)<\/li>\n
          • CNS repair:<\/strong> Improved neurological function in rat stroke models; promoted oligodendrocyte differentiation and remyelination (Sobel RA et al., 2005)<\/li>\n<\/ul>\n

            TB500 Research References<\/h3>\n
              \n
            1. Malinda KM et al. “Thymosin beta4 stimulates directional migration of human umbilical vein endothelial cells.” FASEB J<\/em>, 1997;11(6):474\u2013481.<\/li>\n
            2. Smart N et al. “Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.” Natur<\/em>, 2007;445(7124):177\u2013182.<\/li>\n
            3. Goldstein AL et al. “Thymosin beta4: a multi-functional regenerative peptide.” Expert Opin Biol Ther<\/em>, 2012;12(1):37\u201351.<\/li>\n
            4. Sosne G et al. “Thymosin beta 4 promotes corneal wound healing and decreases inflammation in vivo following alkali injury.” Exp Eye Res<\/em>, 2002;74(2):293\u2013299.<\/li>\n<\/ol>\n\n

              GHK-Cu (Copper Tripeptide): Extracellular Matrix Architect<\/h2>\n

              What Is GHK-Cu?<\/h3>\n

              GHK-Cu is a naturally occurring copper complex of the tripeptide glycine-histidine-lysine (GHK)<\/strong>, first isolated from human plasma by Pickart and Thaler in 1973. GHK plasma concentrations decline dramatically with age \u2014 from approximately 200 ng\/mL at age 20 to under 80 ng\/mL by age 60 \u2014 correlating with reduced wound healing capacity, skin thinning, and systemic tissue decline. Copper chelation (GHK-Cu) is essential for biological activity, enabling the tripeptide to enter cells and modulate gene expression at an extraordinary scale.<\/p>\n

              Mechanism of Action<\/h3>\n
                \n
              • Collagen synthesis:<\/strong> Stimulates production of collagen types I, III, and VI in fibroblasts; upregulates COL1A1, COL3A1, and decorin gene expression<\/li>\n
              • MMP\/TIMP balance:<\/strong> Simultaneously activates MMPs (for matrix remodelling) and their inhibitors TIMPs \u2014 maintaining balanced ECM turnover, not degradation<\/li>\n
              • Genomic reprogramming:<\/strong> A landmark 2012 study demonstrated that GHK-Cu modulates expression of 32% of the human genome via regulatory gene activation, including VEGF, HGF, and anti-inflammatory cytokines (Pickart et al., 2012)<\/li>\n
              • Antioxidant:<\/strong> Copper-dependent SOD (superoxide dismutase) activation; direct free radical scavenging reducing oxidative damage at wound sites<\/li>\n
              • Neural regeneration:<\/strong> Promotes nerve outgrowth and branching; activates BDNF (Brain-Derived Neurotrophic Factor) expression in neural tissue models<\/li>\n<\/ul>\n

                Key Preclinical and Clinical Findings<\/h3>\n
                  \n
                • Skin regeneration:<\/strong> Topical GHK-Cu increased skin thickness by 120% and collagen density by 70% in aged skin models (Abdulghani AA et al., 1998 \u2014 J Dermatol Surg<\/em>)<\/li>\n
                • Wound healing:<\/strong> Accelerated healing of chronic leg ulcers and improved wound contraction rates in controlled clinical studies (Leyden JJ et al., 1990)<\/li>\n
                • Hair growth:<\/strong> Stimulates hair follicle size and growth rate; increases KGF (keratinocyte growth factor) expression (Uno H et al., 1996)<\/li>\n
                • Lung protection:<\/strong> Attenuates pulmonary fibrosis in bleomycin models by reducing TGF-β1 and collagen deposition (Campbell JD et al., 2019)<\/li>\n<\/ul>\n

                  GHK-Cu Research References<\/h3>\n
                    \n
                  1. Pickart L et al. “The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging.” Oxid Med Cell Longev<\/em>, 2012;2012:324832.<\/li>\n
                  2. Pickart L, Margolina A. “Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.” Int J Mol Sci<\/em>, 2018;19(7):1987.<\/li>\n
                  3. Gorouhi F, Maibach HI. “Role of topical peptides in preventing or treating aged skin.” Int J Cosmet Sci<\/em>, 2009;31(5):327\u2013345.<\/li>\n
                  4. Canapp SO et al. “The effect of topical tripeptide-copper complex on healing of ischemic open wounds.” Vet Surg<\/em>, 2003;32(6):515\u2013523.<\/li>\n<\/ol>\n\n

                    Why This Stack? Synergistic Pathways Explained<\/h2>\n\n\n\n\n\n\n\n
                    Peptide<\/th>\nPrimary Target<\/th>\nKey Pathway<\/th>\n<\/tr>\n<\/thead>\n
                    BPC-157<\/td>\nTendon, gut, bone, CNS<\/td>\nFAK-paxillin \/ VEGF \/ NO-system<\/td>\n<\/tr>\n
                    TB500<\/td>\nMuscle, cardiac, cornea, skin<\/td>\nG-actin sequestration \/ angiogenesis \/ ILK-Akt<\/td>\n<\/tr>\n
                    GHK-Cu<\/td>\nECM, skin, hair, lung, nerves<\/td>\nCollagen synthesis \/ MMP-TIMP balance \/ genomic reprogramming<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

                    While BPC-157 initiates the cellular signalling cascade for injury-site repair and GHK-Cu rebuilds the structural collagen scaffold, TB500 supplies the vascular network (via angiogenesis) required to sustain both processes. No single peptide covers all three functions \u2014 making this combination uniquely comprehensive for preclinical tissue repair research.<\/p>\n

                    All products in this bundle are supplied for research purposes only. Not for human consumption. Not evaluated by any regulatory authority.<\/em><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

                    The ultimate tissue repair research bundle. BPC-157+TB500 accelerates multi-tissue healing while GHK-Cu restores collagen matrix integrity. Save 10% vs. individual product prices.<\/p>","protected":false},"featured_media":858,"comment_status":"open","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"product_brand":[],"product_cat":[55],"product_tag":[209,210,211,255,208,206,207],"class_list":["post-882","product","type-product","status-publish","has-post-thumbnail","product_cat-recovery-healing","product_tag-anti-inflammatory","product_tag-gut-healing","product_tag-neuroprotection","product_tag-research-grade","product_tag-tendon-healing","product_tag-tissue-repair","product_tag-wound-healing","first","instock","shipping-taxable","product-type-grouped"],"_links":{"self":[{"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product\/882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/comments?post=882"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/media\/858"}],"wp:attachment":[{"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/media?parent=882"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product_brand?post=882"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product_cat?post=882"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/decodepeptides.com\/de\/wp-json\/wp\/v2\/product_tag?post=882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}